Micrus Endovascular to get technology rights from ReVasc
Executive Summary
Micrus Endovascular (implants and devices for cerebral vascular conditions) has signed a letter of intent to acquire rights to an ischemic stroke treatment technology from ReVasc.
Deal Industry
- Medical Devices
Deal Status
- Preliminary
Deal Type
-
Alliance
- Marketing (Licensing)
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice